Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Wondering what the best travel cards with low annual fees are? Find great options that provide excellent rewards without hefty fees.
18,854 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Willamette Valley Bank will stop originating residential mortgages by March 31, citing stiff competition and a prolon...
Netflix has opted not to top Paramount's offer, prompting Warner Bros. Discovery to align with Paramount. The move co...
A trio of megacaps—NVIDIA, Alphabet, and Amazon—has caught the eye of stocks wall street analysts as the era of AI fu...
Trump’s historic line about abandoning nation-building now echoes into a markets-focused era. This piece explains wha...
When a stimulus move hits a niche chip maker like Tower Semiconductor, investors ask what really caused it. This arti...
A quick look at why COEUR Mining stock moved sharply and what it means for investors. This guide breaks down the main...
February highlighted a split in space stocks: Iridium rose on stabilizing results, while Redwire and Spacemobile tumb...
A fictional scenario examines a potential shareholder class-action targeting coinbase brian armstrong execs over cust...
Liquidity squeezes in major private credit funds put the trillion private credit boom under stress. Bitcoin could be ...
A rising stake in Instacart highlights how investment groups are pricing the shift to digital grocery. This article e...
When Paramount beat Netflix in the bid for Warner Bros. Discovery’s assets, headlines screamed victory. This piece di...